BioLargo, Inc. (NASDAQ:BLGO) Short Interest Update

Key Points

• BioLargo, Inc. experienced a substantial increase in short interest, rising by 441.9% to 126,800 shares by the end of July.
• The company's stock opened at $0.18, with a market capitalization of $56.65 million and a PE ratio of -18.41.
• BioLargo focuses on developing technologies for environmental solutions including water contamination, wastewater treatment, and air quality control.

BioLargo, Inc. (NASDAQ:BLGO - ) was the recipient of a significant growth in short interest during the month of July. As of July 31st, there was short interest totaling 126,800 shares, agrowthof441.9% from the July 15th total of 23,400 shares. Based on an average trading volume of 996,300 shares, the short-interest ratio is currently 0.1 days. Approximately0.1% of the company's shares are short sold. Approximately0.1% of the company's shares are short sold. Based on an average trading volume of 996,300 shares, the short-interest ratio is currently 0.1 days.

BioLargo Stock Performance

BLGO opened at $0.18 on Friday. BioLargo has a one year low of $0.16 and a one year high of $0.32. The stock has a market capitalization of $56.65 million, a PE ratio of -18.41 and a beta of 0.05. The business's 50 day moving average price is $0.19 and its 200 day moving average price is $0.23. The company has a debt-to-equity ratio of 0.03, a quick ratio of 2.24 and a current ratio of 2.31.

BioLargo Company Profile

BioLargo, Inc invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.